This week’s New England Journal of Medicine includes a study from Norway on efficacy of colonoscopy. The conclusions aren’t necessarily applicable to colorectal cancer screening in the U.S.
Here are a few issues to keep in mind when reading the study and talking with your patients:
Talking points for your patients:
If you know your adenoma detection rate, compare it to the rates of the doctors in the study.
Thanks to AGA President John Carethers and David Lieberman, chair of the AGA Executive Committee on the Screening Continuum, for his comments on this study. Read more about AGA’s CRC task force and our call for a national screening program.